Evidence-Based Treatment for Epilepsy-Related Depression
PEARLS for Adults with Epilepsy was designed to treat major depression, minor depression and dysthymic disorder in adults with epilepsy. Individuals with epilepsy are more likely to be depressed than are individuals in the general population. In fact, studies have shown that between
30 - 50% of individuals with epilepsy experience significant depressive symptoms.
Between 2006 and 2009, University of Washington
Health Promotion Research Center investigators conducted a
randomized controlled trial funded by the
Centers for Disease Control and Prevention to test the effectiveness of the PEARLS Program in all-age adults with epilepsy. Preliminary findings suggest that, as was found in the first PEARLS randomized controlled trial, individuals with epilepsy treated with the PEARLS Program were more likely to experience a reduction in depressive symptoms as compared to those receiving usual care. Final study results have been submitted for publication in 2010.
The PEARLS Program is well suited for individuals with epilepsy since many of the factors associated with depression in this population are related to decreases in function, ambulation and social support, and these are some of the main areas targeted in the
PEARLS approach .